ClearPoint Neuro Inc. (CLPT)
NASDAQ: CLPT
· Real-Time Price · USD
27.38
2.33 (9.30%)
At close: Oct 03, 2025, 3:59 PM
27.88
1.83%
After-hours: Oct 03, 2025, 07:58 PM EDT
ClearPoint Neuro Revenue Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biologics And Drug Delivery - Disposable Products Revenue | 1.87M | 1.78M | 2.06M | 1.67M | 553K | 455K | 346K | 594K | 798K | 1.23M | 850K | 72.5K | 244.95K | 284.91K |
Biologics And Drug Delivery - Disposable Products Revenue Growth | +5.11% | -13.68% | +23.40% | +202.17% | +21.54% | +31.50% | -41.75% | -25.56% | -34.86% | +44.12% | +1072.41% | -70.40% | -14.03% | n/a |
Biologics And Drug Delivery Revenue | 4.74M | 4.69M | 4.43M | 4.33M | 4.31M | 3.49M | 3.37M | 2.68M | 2.25M | 2.41M | 2.15M | n/a | n/a | n/a |
Biologics And Drug Delivery Revenue Growth | +1.02% | +5.87% | +2.40% | +0.46% | +23.52% | +3.53% | +25.86% | +19.15% | -6.73% | +11.79% | n/a | n/a | n/a | n/a |
Capital Equipment And Software - Services Revenue | 350K | 283K | 279K | 258K | 250K | 276K | 208K | 218K | 193K | 185K | 189K | n/a | n/a | n/a |
Capital Equipment And Software - Services Revenue Growth | +23.67% | +1.43% | +8.14% | +3.20% | -9.42% | +32.69% | -4.59% | +12.95% | +4.32% | -2.12% | n/a | n/a | n/a | n/a |
Capital Equipment And Software - Systems and Software Products Revenue | 694K | 234K | 552K | 687K | 1.16M | 81K | 173K | 178K | 287K | 434K | 450K | n/a | n/a | n/a |
Capital Equipment And Software - Systems and Software Products Revenue Growth | +196.58% | -57.61% | -19.65% | -40.52% | +1325.93% | -53.18% | -2.81% | -37.98% | -33.87% | -3.56% | n/a | n/a | n/a | n/a |
Capital Equipment And Software Revenue | 1.04M | 517K | 831K | 945K | 1.41M | 357K | 381K | 396K | 480K | 619K | 639K | n/a | n/a | n/a |
Capital Equipment And Software Revenue Growth | +101.93% | -37.79% | -12.06% | -32.74% | +293.56% | -6.30% | -3.79% | -17.50% | -22.46% | -3.13% | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 7.41M | 7.92M | 7.03M | 6.7M | 6.61M | 6.13M | 6.07M | 5.74M | 6.65M | 5.89M | 4.16M | 5.05M | 5.18M | 4.58M | 4.54M | 4.26M | 3.57M | 3.23M | 2.72M | 2.86M | 2.49M | 2.58M | 2.82M | 2.09M | 2.17M | 1.97M | 2.09M | 1.84M | 2.01M | 1.92M | 2.27M | 1.77M | 1.92M | 2.05M | 2.22M | 1.89M | 1.89M | 1.97M | 1.76M | 2.13M | 2.19M | 2.29M |
Selling, General, and Administrative Revenue Growth | -6.43% | +12.54% | +4.92% | +1.47% | +7.76% | +1.05% | +5.68% | -13.70% | +12.92% | +41.58% | -17.67% | -2.38% | +13.11% | +0.88% | +6.45% | +19.25% | +10.58% | +18.65% | -4.85% | +15.00% | -3.40% | -8.52% | +34.60% | -3.60% | +10.01% | -5.34% | +13.15% | -8.54% | +5.20% | -15.67% | +28.61% | -7.82% | -6.58% | -7.58% | +17.63% | -0.10% | -4.37% | +12.05% | -17.39% | -2.50% | -4.42% | n/a |
Research and Development Revenue | 3.83M | 3.38M | 3.33M | 3.31M | 3.12M | 2.63M | 2.65M | 2.43M | 3.6M | 3.02M | 3.62M | 2.45M | 2.28M | 2.53M | 2.73M | 2.63M | 2.12M | 1.56M | 1.82M | 1.21M | 822.3K | 829.53K | 880.33K | 761.88K | 697.8K | 584.54K | 481.29K | 617.24K | 665.31K | 546.33K | 582.16K | 589.72K | 1.08M | 557.7K | 529.71K | 691.33K | 749.94K | 657.19K | 522.61K | 480.28K | 426.93K | 527.51K |
Research and Development Revenue Growth | +13.32% | +1.41% | +0.51% | +6.25% | +18.86% | -1.02% | +9.18% | -32.62% | +19.25% | -16.58% | +47.74% | +7.40% | -9.83% | -7.35% | +3.95% | +23.88% | +35.83% | -14.36% | +50.95% | +47.03% | -0.87% | -5.77% | +15.55% | +9.18% | +19.38% | +21.45% | -22.03% | -7.23% | +21.78% | -6.15% | -1.28% | -45.61% | +94.41% | +5.28% | -23.38% | -7.82% | +14.11% | +25.75% | +8.81% | +12.50% | -19.07% | n/a |
Sales and Marketing Revenue | 4.02M | 3.83M | 3.81M | 3.55M | 3.83M | 3.29M | 3.35M | 2.84M | 3.47M | 2.93M | 3.19M | 2.14M | 2.19M | 1.84M | 1.84M | 1.83M | 1.59M | 1.57M | 1.47M | 1.49M | 1.12M | 1.3M | 1.51M | 1.06M | 1.14M | 1.04M | 879K | 764.6K | 926.23K | 962.21K | 1.01M | 899.1K | 979.9K | 1.07M | 3.78M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales and Marketing Revenue Growth | +4.83% | +0.76% | +7.21% | -7.43% | +16.53% | -1.70% | +17.81% | -18.22% | +18.45% | -7.97% | +48.99% | -2.19% | +18.54% | +0.38% | +0.66% | +14.70% | +1.08% | +7.29% | -1.67% | +32.78% | -13.42% | -13.92% | +41.90% | -6.99% | +9.83% | +18.40% | +14.96% | -17.45% | -3.74% | -4.84% | +12.47% | -8.25% | -8.10% | -71.77% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |